Authors


Brent P. Forester, MD, MSc

Latest:

The Essential Role of Population Health During and Beyond COVID-19

The authors detail how population health management enables health systems to promote public health, strengthen health system resiliency, and support financial recovery during and beyond coronavirus disease 2019 (COVID-19).


Sunita Thapa, MPH

Latest:

Risk Adjusting for Medicaid Participation in Medicare Advantage

When comparing risk-adjustment approaches based on Medicaid status of Medicare beneficiaries, this analysis found that predicted spending levels varied depending on states’ Medicaid eligibility criteria.


Darin Okuda, MD

Latest:

Future of MS Management

Key opinion leaders in MS provide closing thoughts on the future of MS treatment including digital therapeutics, new generics, and pipeline drugs on the horizon.


JoAnn V. Pinkerton, MD, FACOG, MSCP

Latest:

Closing Thoughts: Evolving Treatment Paradigms in Menopause Management

Panelists express their gratitude for the informative discussion and share their final thoughts on the evolving landscape of menopause management and the potential impact of new therapies on improving patient outcomes.


Fei Teng, MS

Latest:

Continuously Updated Forecasting of SARS-CoV-2 in a Regional Health System

This study presents a methodology for forecasting demand of COVID-19 on health resources in an integrated health system.


Daniel Weisdorf, MD

Latest:

Provider Barriers in Uptake of Biosimilars: Case Study on Filgrastim

Previous studies have found modest uptake of biosimilars in both commercial and Medicare populations. This study finds that the uptake varies between the rural and urban provider settings.



Haydar Frangoul, MD, MS

Latest:

Nearly All Patients Who Received Exa-Cel for SCD Are Hospital Free After a Year, Data Show

Haydar Frangoul, MD, MS, medical director, Pediatric Hematology/Oncology for Sarah Cannon Research Institute at TriStar Centennial Children’s Hospital, Nashville, presented the data on the long-term efficacy and safety for participants with sickle cell disease (SCD) who received exa-cel.


John W. Ostrominski, MD

Latest:

Personalized Care Key as Tirzepatide Use Expands Rapidly

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.


David J. Meyers, PhD, MPH

Latest:

The Impacts of Supplemental Benefits on Medicare Advantage Plan Composition

After evaluating the association between the expanded Medicare Advantage supplemental benefits and plan composition, authors determined that adoption was not associated with large demographic shifts in enrollment.


Enam Noor, CEO and founder of Insightin Health

Latest:

Contributor: Advancing Health Care Consumerism Begins With Adopting a Retail Mindset

Adopting a retail mindset, where patients are the primary focus of innovations, could help advance health care consumerism in the future.


Mindy M. Cheng, PhD

Latest:

Real-world HIV Diagnostic Testing Patterns in the United States

This retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory.


Joanie Chung, MPH

Latest:

Antibiotic Practice Patterns With Procalcitonin Levels in Patients With Acute Lower Respiratory Tract Infection

Although clinical trials have demonstrated the utility of procalcitonin (PCT) testing and potential benefit on antibiotic stewardship, findings suggest that clinicians do not order PCT testing with regularity and also prioritize clinical judgment over PCT results.


H. John Beardsley, MBA

Latest:

Identifying the Right Metrics to Evaluate the Impact of the IRA: H. John Beardsley and Fauzea Hussain

Evaluating the impact of the Inflation Reduction Act (IRA) will require real-time data and effective therapy metrics, explained H. John Beardsley, MBA, of CoverMyMeds; and Fauzea Hussain, MPH, of McKesson.


Michael J. Mugavero, MD, MHSc

Latest:

Measuring Continuity of Care for Diabetes: Which Visits to Include?

This study examined how inclusion of different provider specialties affected Continuity of Care Index values, year-to-year stability, and association with emergency department visits.


KariLynn Dowling-McClay, PharmD, MPH

Latest:

COVID-19 Vaccine Hesitancy and Health Literacy in US Southern States

COVID-19 vaccine hesitancy is not associated with health literacy. Personal perception of threat was associated with reduced vaccine hesitancy.


Cassandra Leighton, PhD, MPH

Latest:

Predicting Opioid Use Disorder and Associated Risk Factors in a Medicaid Managed Care Population

A Medicaid managed care organization developed a machine learning model to identify opioid use disorder (OUD) risk factors and predict OUD incidence in its multistate population.


Julie A. Royalty

Latest:

Oncology Alternative Payment Models: Lessons From Commercial Insurance

Developing alternative payment models for commercial populations in specialties such as oncology is rife with practical challenges. Leading payers and practices share lessons to date.


Noah Greenspan, DPT, PT, CCS, EMT-B
Noah Greenspan, DPT, PT, CCS, EMT-B

Latest:

Redefining Long COVID Care With Personalized Treatment

To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.


Nancy P. Ford, MSW, LCSW

Latest:

Impact of Advance Care Planning Consults on Advance Directives Completion

Implementing advance care planning consults can increase advance directive completion rates. The authors demonstrate the impact of consults on completed advance directives in the medical record.


Naomi Dempsey, MD

Latest:

ASCO 2024 Review and Needed Future Research in CDK4/6 inhibitors Early Breast Cancer

A panel of experts review ASCO 2024 and the need for future research in CDK4/6 inhibitors.


Rudra Mehta, BS

Latest:

Machine Intelligence for Early Targeted Precision Management and Response to Outbreaks of Respiratory Infections

This paper evaluates novel machine intelligence to predict patients at risk of severe respiratory infections and recommend postacute care providers likely to reduce infection risk.


Giorgio Tarchini, MD

Latest:

Managed Care COVID-19 Outcomes in a Population Health Program

Data from 38,193 patients showed that managed care patients have COVID-19 risk factors similar to those of the general population and that a population health program decreased mortality.


Alain Gay, MD

Latest:

Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes

This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.


Daphne T. Hao

Latest:

Privately Negotiated Facility Fees at Ambulatory Surgery Centers and Hospitals

Private negotiated facility fees at hospitals are on average double the ambulatory surgery center facility fees for common outpatient procedures.


Sam Elgawly, MD

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Mohammad Jafari, HBSc

Latest:

The Persistent Pandemic of Violence Against Health Care Workers

The problem of violence against health care workers has escalated across the world, and tackling this issue requires the support of administrators.


Sajana K. Patel, MPH

Latest:

Transitional Care Management Visits to Improve Coordination of Care

Inspira Care Connect, LLC, an accountable care organization, incorporated transitional care management services into its postdischarge follow-up process to prevent avoidable utilization of health care services and costs.


Gunnar Esiason

Latest:

Contributor: It’s Time to Talk About Paying Clinical Trial Participants More

There is wide variation in the governance over research participant pay, and with rapid advances in technology enabling trial access, industry should step up and pay patients what they are worth, says Gunnar Esiason, a patient advocate living with cystic fibrosis.


Anita H. Yuan, PhD, MPH

Latest:

Patients’ Needs Following Emergency Care for Ambulatory Care–Sensitive Conditions

To inform intervention development, we assessed for medication changes and patient care needs following treat-and-release Veterans Affairs emergency department visits for chronic ambulatory care–sensitive conditions.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo